Purdue University researchers have developed a new approach to treating the fourth-leading cause of death worldwide – lower respiratory infections.
All news from Thoracic Medicine
Heart and thrombosis are responsible for much of the morbidity and mortality associated with Duchenne muscular dystrophy (DMD). Although regular monitoring of pulmonary function is recommended in order to detect deterioration, compliance with routine testing, such as hospital-based spirometry, is frequently poor. A new study in the Journal of Neuromuscular Diseases describes the at-home use of a child-compatible, hand-held device (HHD) that makes monitoring pulmonary function in teens more convenient and provides the data needed for better disease management.
Heart disease has been the leading cause of death in the United States for more than a century, ever since the early 1900s when it displaced acute diseases for the distinction. Now a growing number of states are crowning a new leading cause of death: cancer.
In an article published online by Frontiers in Endocrinology, researchers at the Medical University of South Carolina (MUSC) report that they have identified a potential therapeutic target for lung fibrosis or scarring.
The CRISPR-Cas9 gene editing system may be able to restore the effectiveness of first-line chemotherapies used to treat lung cancer by deleting or " knocking out " a gene in cancer tumors that helps the tumors develop resistance to the drugs.
Scientists at Cincinnati Children's Hospital Medical Center have created and tested a decision tool that appears to be the most accurate, non-invasive method yet developed to predict asthma in young children.
A 40-mg dose of slow-release morphine may be safe for non-severely obese patients with obstructive sleep apnea (OSA), researchers in Australia report.
Mechanical constraints to ventilation play a role in the limited exercise endurance seen in adult survivors of very preterm birth.
Two months of mandibular-advancement therapy significantly reduced the severity of obstructive sleep apnea (OSA) in patients with severe OSA, but had no effect on inflammatory and metabolic biomarkers, a new study from France shows.
Sema4, a patient-centered predictive health company, and the Mount Sinai Health System announced the launch of a five-year collaborative study with Sanofi designed to provide new insights into the biological mechanisms and other factors implicated in asthma. The project will follow nearly 1,200 people with asthma and collect a range of data — from traditional clinical data to genomics, immunological, environmental, and sensor data from mobile devices — to enable sophisticated analysis and advanced network modeling of this complex disease.
Medtronic has announced US Food and Drug Administration approval of its Valiant Navion thoracic stent graft system designed for minimally invasive repair of all lesions of the descending thoracic aorta.
Nocturnal hypoxemia coupled with chronic obstructive pulmonary disease (COPD) increased the risk for cardiovascular events and mortality in female patients with suspected obstructive sleep apnea (OSA), according to a study published in the Annals of the American Thoracic Society.